Farhad Vesuna

3.6k total citations · 1 hit paper
38 papers, 2.5k citations indexed

About

Farhad Vesuna is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Farhad Vesuna has authored 38 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 14 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Farhad Vesuna's work include RNA Research and Splicing (11 papers), Cancer Cells and Metastasis (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Farhad Vesuna is often cited by papers focused on RNA Research and Splicing (11 papers), Cancer Cells and Metastasis (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Farhad Vesuna collaborates with scholars based in United States, Netherlands and Germany. Farhad Vesuna's co-authors include Venu Raman, Paul van Diest, Ala Lisok, Paul T. Winnard, Amy Axel, Nicholas J. Sullivan, Brett M. Hall, Tatiana M. Oberyszyn, A. Kate Sasser and Nilsa C. Ramirez and has published in prestigious journals such as PLoS ONE, Cancer Research and Analytical Biochemistry.

In The Last Decade

Farhad Vesuna

37 papers receiving 2.5k citations

Hit Papers

Interleukin-6 induces an epithelial–mesenchymal transitio... 2009 2026 2014 2020 2009 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells
    2009 605 citations Nicholas J. Sullivan, A. Kate Sasser et al. Oncogene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farhad Vesuna United States 22 1.7k 1.1k 708 273 213 38 2.5k
Gianluca Bossi Italy 30 1.4k 0.8× 988 0.9× 547 0.8× 254 0.9× 192 0.9× 53 2.2k
Petra den Hollander United States 24 1.4k 0.8× 913 0.9× 596 0.8× 229 0.8× 227 1.1× 43 2.2k
Qi‐En Wang United States 29 1.8k 1.1× 777 0.7× 447 0.6× 320 1.2× 125 0.6× 65 2.4k
Nils Brünner Denmark 29 1.2k 0.7× 1.0k 1.0× 972 1.4× 226 0.8× 322 1.5× 96 2.4k
José M.A. Moreira Denmark 31 1.8k 1.1× 656 0.6× 670 0.9× 239 0.9× 210 1.0× 79 2.8k
Alicia S. Chung United States 11 1.4k 0.9× 798 0.7× 517 0.7× 521 1.9× 153 0.7× 16 2.3k
Simona Ronzoni Italy 17 2.2k 1.3× 1.3k 1.3× 659 0.9× 328 1.2× 193 0.9× 29 3.2k
Rudolf Nenutil Czechia 24 1.7k 1.0× 895 0.8× 919 1.3× 202 0.7× 215 1.0× 100 2.6k
Hilla Solomon Israel 20 1.1k 0.7× 883 0.8× 551 0.8× 242 0.9× 148 0.7× 29 1.8k
Caigang Liu China 26 1.4k 0.8× 850 0.8× 877 1.2× 291 1.1× 531 2.5× 132 2.7k

Countries citing papers authored by Farhad Vesuna

Since Specialization
Citations

This map shows the geographic impact of Farhad Vesuna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhad Vesuna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhad Vesuna more than expected).

Fields of papers citing papers by Farhad Vesuna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farhad Vesuna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhad Vesuna. The network helps show where Farhad Vesuna may publish in the future.

Co-authorship network of co-authors of Farhad Vesuna

This figure shows the co-authorship network connecting the top 25 collaborators of Farhad Vesuna. A scholar is included among the top collaborators of Farhad Vesuna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farhad Vesuna. Farhad Vesuna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Winnard, Paul T., Farhad Vesuna, & Venu Raman. (2025). DExD-box RNA helicases in human viral infections: Pro- and anti-viral functions. Antiviral Research. 235. 106098–106098. 1 indexed citations
2.
Vesuna, Farhad, Paul T. Winnard, Marise R. Heerma van Voss, et al.. (2025). Inhibition of DDX3 modulates immune signaling in aggressive breast cancers. Cancer Letters. 634. 218065–218065.
3.
Winnard, Paul T., Farhad Vesuna, Guus M. Bol, et al.. (2024). Targeting RNA helicase DDX3X with a small molecule inhibitor for breast cancer bone metastasis treatment. Cancer Letters. 604. 217260–217260. 7 indexed citations
4.
Mori, Noriko, Jiefu Jin, Balaji Krishnamachary, et al.. (2023). Functional roles of FAP-α in metabolism, migration and invasion of human cancer cells. Frontiers in Oncology. 13. 1068405–1068405. 6 indexed citations
5.
Winnard, Paul T., Farhad Vesuna, & Venu Raman. (2020). Targeting host DEAD-box RNA helicase DDX3X for treating viral infections. Antiviral Research. 185. 104994–104994. 28 indexed citations
6.
Winnard, Paul T., et al.. (2020). Divergent organ-specific isogenic metastatic cell lines identified using multi-omics exhibit differential drug sensitivity. PLoS ONE. 15(11). e0242384–e0242384. 4 indexed citations
7.
Tantravedi, Saritha, Farhad Vesuna, Paul T. Winnard, et al.. (2018). Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33. Translational Oncology. 12(1). 96–105. 37 indexed citations
8.
Voss, Marise R. Heerma van, Kai Kammers, Farhad Vesuna, et al.. (2018). Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach. Translational Oncology. 11(3). 755–763. 25 indexed citations
9.
Voss, Marise R. Heerma van, Farhad Vesuna, Guus M. Bol, et al.. (2017). Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer. OncoTargets and Therapy. Volume 10. 3501–3513. 24 indexed citations
10.
Xie, Min, Farhad Vesuna, Saritha Tantravedi, et al.. (2016). RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3. Cancer Research. 76(21). 6340–6350. 61 indexed citations
11.
Vos, Shoko, Farhad Vesuna, Venu Raman, P. J. van Diest, & Petra van der Groep. (2015). miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers. Oncotarget. 6(31). 32115–32137. 22 indexed citations
12.
Vesuna, Farhad, Ala Lisok, J. Brian Kimble, et al.. (2011). Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-α. Oncogene. 31(27). 3223–3234. 133 indexed citations
13.
Botlagunta, Mahendran, Balaji Krishnamachary, Farhad Vesuna, et al.. (2011). Expression of DDX3 Is Directly Modulated by Hypoxia Inducible Factor-1 Alpha in Breast Epithelial Cells. PLoS ONE. 6(3). e17563–e17563. 36 indexed citations
14.
Vesuna, Farhad, Ala Lisok, J. Brian Kimble, & Venu Raman. (2009). Twist Modulates Breast Cancer Stem Cells by Transcriptional Regulation of CD24 Expression. Neoplasia. 11(12). 1318–1328. 195 indexed citations
15.
Sullivan, Nicholas J., A. Kate Sasser, Amy Axel, et al.. (2009). Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells. Oncogene. 28(33). 2940–2947. 605 indexed citations breakdown →
16.
Botlagunta, Mahendran, Farhad Vesuna, Yelena Mironchik, et al.. (2008). Oncogenic role of DDX3 in breast cancer biogenesis. Oncogene. 27(28). 3912–3922. 187 indexed citations
17.
Winnard, Paul T., et al.. (2008). Hypoxia-induced human endonuclease G expression suppresses tumor growth in a xenograft model. Cancer Gene Therapy. 15(10). 645–654. 6 indexed citations
18.
Duriseti, Sai, Paul T. Winnard, Yelena Mironchik, et al.. (2006). HOXA5 Regulates hMLH1 Expression in Breast Cancer Cells. Neoplasia. 8(4). 250–258. 27 indexed citations
19.
Mironchik, Yelena, Paul T. Winnard, Farhad Vesuna, et al.. (2005). Twist Overexpression Induces In vivo Angiogenesis and Correlates with Chromosomal Instability in Breast Cancer. Cancer Research. 65(23). 10801–10809. 241 indexed citations
20.
Vesuna, Farhad, Paul Winnard, & Venu Raman. (2005). Enhanced green fluorescent protein as an alternative control reporter to Renilla luciferase. Analytical Biochemistry. 342(2). 345–347. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gianluca Bossi Breakdown of academic impact, for papers by Petra den Hollander Breakdown of academic impact, for papers by Qi‐En Wang Breakdown of academic impact, for papers by Nils Brünner Breakdown of academic impact, for papers by José M.A. Moreira Breakdown of academic impact, for papers by Alicia S. Chung Breakdown of academic impact, for papers by Simona Ronzoni Breakdown of academic impact, for papers by Rudolf Nenutil Breakdown of academic impact, for papers by Hilla Solomon Breakdown of academic impact, for papers by Caigang Liu
Rankless by CCL
2026